Generics Firms Deterred From Continuous Manufacturing
Cost And Lack Of Know-How Are Cited As Factors
Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.
